CorMedix Inc — Quarterly Financial Statistics (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -13.65 M-5.61 M19.74 M29.99 M30.86 M 74.97 M Cash from investing activities 6.32 M-304.16 K-194.82 K-20.21 M-291.32 M -312.03 M Cash from financing activities 14.07 M11.28 M6.09 M83.24 M150.53 M 251.15 M Free cash flow -13.66 M-5.62 M19.73 M29.97 M30.35 M 74.42 M

Notícias

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11

Citizens reitera classificação de Market Outperform para ações da CorMedix

CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside

Ações da CorMedix sobem após anúncio de plano de recompra de US$ 75 milhões

CorMedix stock rises after announcing $75 million share buyback plan

CorMedix anuncia programa de recompra de ações de US$ 75 milhões

CorMedix announces $75 million share repurchase program